A pharmacodynamic model of Aurora kinase inhibitors in the spindle assembly checkpoint

Hitesh B Mistry1, David E MacCallum, Robert C Jackson

  • 1Division of Mathematics, University of Dundee, Dundee DD1 4HN, Scotland, UK.

Insights

Mathematical modeling offers a novel way to understand how inhibiting Aurora kinases affects cell division during mitosis. This approach helps predict cancer drug efficacy by linking inhibitor concentration to cell damage.

Area of Science:

  • Cell Biology
  • Pharmacology
  • Mathematical Biology

Background:

  • Mitosis is crucial for accurate chromosome segregation, with Aurora kinases playing a central role.
  • Aurora kinases are key targets for cancer therapy, but their complex functions complicate drug development.
  • Standard methods struggle to link Aurora kinase inhibitor concentration to treatment efficacy.

Purpose of the Study:

  • To develop a novel mathematical modeling approach to study Aurora kinases in mitosis.
  • To create a pharmacodynamic model for Aurora A and B kinases within the spindle assembly checkpoint.
  • To differentiate the effects of inhibiting Aurora A, Aurora B, or both on cell behavior.

Main Methods:

  • Developed a pharmacodynamic mathematical model.
  • Encapsulated key roles of Aurora A and B kinases in the spindle assembly checkpoint.
  • Used the model to predict cell behavior under different inhibition scenarios.

Main Results:

  • The model qualitatively differentiates the effects of inhibiting Aurora A, Aurora B, and dual inhibition.
  • Predicted cell behavior provides insights into the relationship between inhibitors and cell damage.
  • Enabled predictions linking inhibitor concentration, biomarkers, and cell damage.

Conclusions:

  • Mathematical modeling provides a powerful approach to understand Aurora kinase inhibitor effects.
  • This method can predict qualitative relationships between drug concentration, biomarkers, and cell damage.
  • Offers a new strategy for developing targeted cancer therapies involving Aurora kinases.

Related Concept Videos

The Spindle Assembly Checkpoint02:19

The Spindle Assembly Checkpoint

The spindle assembly checkpoint is a molecular surveillance mechanism ensuring the fidelity of chromosome segregation during anaphase. The checkpoint monitors the completion of all the prerequisite steps before chromosome segregation to determine whether the segregation process should proceed or be delayed.
Many proteins function together to control the spindle assembly checkpoint. Mutations affecting these proteins may allow cells to proceed into anaphase prematurely, resulting in the...
The Spindle Assembly Checkpoint02:19

The Spindle Assembly Checkpoint

The spindle assembly checkpoint is a molecular surveillance mechanism ensuring the fidelity of chromosome segregation during anaphase. The checkpoint monitors the completion of all the prerequisite steps before chromosome segregation to determine whether the segregation process should proceed or be delayed.
Many proteins function together to control the spindle assembly checkpoint. Mutations affecting these proteins may allow cells to proceed into anaphase prematurely, resulting in the...
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...